Type 2 Diabetes Mellitus

63 competing products in clinical development for Type 2 Diabetes Mellitus.

Pipeline by Phase

Pre-clinical2

Phase 111

Phase 1/21

Phase 28

Phase 2/31

Phase 325

Approved15

All Products (63)

Product	Company	Stage	Status	Hype
Insulin Lispro Mix25 + Insulin Lispro Mix50	Eli Lilly	Approved	Completed	43
exenatide and sitagliptin + exenatide and placebo	Eli Lilly	Approved	Completed	43
Insulin Analog Mid Mixture + Basal Insulin Analog	Eli Lilly	Approved	Completed	43
Insulin Glargine	Eli Lilly	Approved	Completed	43
Rosuvamibe® Tab + Monorova® Tab	Yuhan	Approved	Completed	43
High-dose colesevelam + Low-dose colesevelam	Daiichi Sankyo	Approved	Completed	43
Ipragliflozin	Astellas Pharma	Approved	Completed	43
ipragliflozin + placebo	Astellas Pharma	Approved	Completed	43
Oral administration of Ipragliflozin	Astellas Pharma	Approved	Completed	43
Prostaglandin I2 + Placebo	Astellas Pharma	Approved	Completed	43
Ipragliflozin + Insulin	Astellas Pharma	Approved	Completed	43
Triple combination therapy group + Premixed insulin therapy group	Sun Pharmaceutical	Approved	Completed	43
exenatide once weekly + insulin detemir	Eli Lilly	Phase 3	Completed	40
Welchol + Placebo	Daiichi Sankyo	Phase 3	Completed	40
Pioglitazone + Placebo + Rivoglitazone + Rivoglitazone	Daiichi Sankyo	Phase 3	Completed	40
Metformin HCl and Colesevelam Placebo + Metformin HCl tablets and Colesevelam tablets + Colesevelam placebo + Colesevelam	Daiichi Sankyo	Phase 3	Completed	40
Olmesartan medoxomil + Losartan	Daiichi Sankyo	Phase 3	Completed	40
Colesevelam + Placebo + Pioglitazone	Daiichi Sankyo	Phase 3	Completed	40
ASP1941 + placebo	Astellas Pharma	Phase 3	Completed	40
Ipragliflozin L-proline + Metformin + Placebo	Astellas Pharma	Phase 3	Completed	40
Placebo + Sulfonylurea	Astellas Pharma	Phase 3	Completed	40
ipragliflozin	Astellas Pharma	Phase 3	Completed	40
ipragliflozin + DPP-4 inhibitor	Astellas Pharma	Phase 3	Completed	40
ipragliflozin	Astellas Pharma	Phase 3	Completed	40
ASP1941 + Placebo	Astellas Pharma	Phase 3	Completed	40
ipragliflozin + nateglinide	Astellas Pharma	Phase 3	Completed	40
ipragliflozin + Placebo + metformin	Astellas Pharma	Phase 3	Completed	40
ipragliflozin + Placebo + Pioglitazone	Astellas Pharma	Phase 3	Completed	40
ipragliflozin + placebo	Astellas Pharma	Phase 3	Completed	40
ipragliflozin + alpha glucosidase inhibitor	Astellas Pharma	Phase 3	Completed	40
Ipragliflozin + Sitagliptin	Astellas Pharma	Phase 3	Completed	40
SPIL1033 + Placebo	Sun Pharmaceutical	Phase 3	Completed	40
MK-0431/ONO-5435 + MK-0431/ONO-5435	Ono Pharmaceutical	Phase 3	Completed	40
Sitagliptin phosphate	Ono Pharmaceutical	Phase 3	Completed	40
Placebo + Sitagliptin phosphate	Ono Pharmaceutical	Phase 3	Completed	40
Placebo + Sitagliptin phosphate	Ono Pharmaceutical	Phase 3	Completed	40
nateglinide	Astellas Pharma	Phase 2/3	Completed	38
exenatide + Placebo	Eli Lilly	Phase 2	Completed	35
Colesevelam hydrochloride + placebo	Daiichi Sankyo	Phase 2	Completed	35
Sitagliptin 100 mg + DS-8500a 25mg + Placebo Tablet + Placebo Capsule	Daiichi Sankyo	Phase 2	Completed	35
DS-8500a 25 mg + DS-8500a 75 mg + placebo	Daiichi Sankyo	Phase 2	Completed	35
10mg DS-8500a tablet + 75mg DS-8500a tablet + placebo	Daiichi Sankyo	Phase 2	Completed	35
metformin + ipragliflozin + glimepiride	Astellas Pharma	Approved	Terminated	35
Beraprost + Aspirin	Astellas Pharma	Approved	Terminated	35
ipragliflozin + Placebo + Metformin	Astellas Pharma	Phase 2	Completed	35
S-707106 Dose A + S-707106 Dose B + S-707106 Dose C + Placebo A tablet + Metformin	Shionogi	Phase 2	Completed	35
ONO-5129	Ono Pharmaceutical	Phase 2	Completed	35
Retatrutide + Placebo	Eli Lilly	Phase 1	Active	33
exenatide once weekly + exenatide once weekly	Eli Lilly	Phase 1/2	Completed	32
Rivoglitazone HCl + rivoglitazone HCl + rivoglitazone HCl + placebo + pioglitazone HCl + pioglitazone HCl + pioglitazone HCl 45 mg + placebo + metformin	Daiichi Sankyo	Phase 3	Terminated	32
add-on pioglitazone + add-on sulphonylurea	AMD Biotech	Approved	UNKNOWN	29
BioChaperone insulin lispro + Humalog®	Eli Lilly	Phase 1	Completed	29
DS-7309 + placebo + Metformin	Daiichi Sankyo	Phase 1	Completed	29
DS-1150b	Daiichi Sankyo	Phase 1	Completed	29
DS-7309 + placebo	Daiichi Sankyo	Phase 1	Completed	29
ASP1941	Astellas Pharma	Phase 1	Completed	29
ASP1941	Astellas Pharma	Phase 1	Completed	29
ASP1941 + Placebo	Astellas Pharma	Phase 1	Completed	29
ASP1941 + Placebo	Astellas Pharma	Phase 1	Completed	29
ASP1941 + Metformin + Placebo	Astellas Pharma	Phase 1	Completed	29
S-707106 + Placebo + Metformin, S-707106 plus metformin + Metformin, placebo plus metformin	Shionogi	Phase 1	Completed	29
DS-8500a + placebo	Daiichi Sankyo	Pre-clinical	Completed	26
Colesevelam HCl	Daiichi Sankyo	Pre-clinical	Completed	26